Kiora Pharmaceuticals Stock Target Price and Analyst Consensus

KPRX
 Stock
  

USD 3.78  0.10  2.72%   

The current analyst and expert consensus on Kiora Pharmaceuticals is Strong Buy, with 1 strong buy opinions. The current projected Kiora Pharmaceuticals target price consensus is 10.0 with 2 analyst opinions. The most common way Kiora Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Kiora Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Kiora Pharmaceuticals. We encourage you to use your own analysis of Kiora Pharmaceuticals to validate this buy or sell advice. Kiora Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Kiora Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 7.071. Please see Macroaxis Advice on Kiora Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  

Kiora Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kiora target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Kiora target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of OpinionsOne
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Kiora analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Kiora stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Kiora Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Kiora Pharmaceuticals Target Price Projection

Kiora Pharmaceuticals' current and average target prices are 3.78 and 10.00, respectively. The current price of Kiora Pharmaceuticals is the price at which Kiora Pharmaceuticals is currently trading. On the other hand, Kiora Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Kiora Pharmaceuticals Market Quote on 3rd of December 2022

Low Price3.58Odds
High Price3.81Odds

3.78

Target Price

Analyst Consensus On Kiora Pharmaceuticals Target Price

Low Estimate5.0Odds
High Estimate15.0Odds
Number of Analysts2
Standard Deviation7.071

10.0

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Kiora Pharmaceuticals and the information provided on this page.

Kiora Pharmaceuticals Analyst Ratings

Kiora Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Kiora Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Kiora Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Kiora Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Kiora Pharmaceuticals Target Price Projections

Kiora Pharmaceuticals's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Kiora Pharmaceuticals and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Kiora depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Kiora Pharmaceuticals including its fundamental analysis.

Additional Kiora Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Kiora Pharmaceuticals is a key component of Kiora Pharmaceuticals valuation and have some predictive power on the future returns of a Kiora Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kiora Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kiora Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.183.6113.14
Details
Intrinsic
Valuation
LowReal ValueHigh
0.265.3014.83
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-1.47-1.33-1.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kiora Pharmaceuticals. Your research has to be compared to or analyzed against Kiora Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Kiora Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kiora Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Software
Invested over 20 shares
Impulse
Invested over 200 shares
Artificial Intelligence
Invested few shares
Top FinTech
Invested over 60 shares
Blockchain
Invested few shares
Macroaxis Index
Invested one share
Disruptive Technologies
Invested one share
Power Stocks
Invested one share
Please see Macroaxis Advice on Kiora Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for analysis

When running Kiora Pharmaceuticals price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
The data published in Kiora Pharmaceuticals' official financial statements usually reflect Kiora Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Kiora Pharmaceuticals. For example, before you start analyzing numbers published by Kiora accountants, it's critical to develop an understanding of what Kiora Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Kiora Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kiora Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Kiora Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kiora Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Kiora Pharmaceuticals' management to manipulate its earnings.